IL-28A (IFN-λ2) modulates lung DC function to promote Th1 immune skewing and suppress allergic airway disease. - Wikidata - awgldk - TriplyDB

IL-28A (IFN-λ2) modulates lung DC function to promote Th1 immune skewing and suppress allergic airway disease.

IL-28A (IFN-λ2) modulates lung DC function to promote Th1 immune skewing and suppress allergic airway disease.

http://www.wikidata.org/entity/Q41863615

about

Interferon lambda: a new sword in cancer immunotherapy Interferon-λ: Immune Functions at Barrier Surfaces and Beyond IFN-λ resolves inflammation via suppression of neutrophil infiltration and IL-1β production.IFN-λ: A New Inducer of Local Immunity against Cancer and Infections Interferon induction and function at the mucosal surface.Borrelia burgdorferi RNA induces type I and III interferons via Toll-like receptor 7 and contributes to production of NF-κB-dependent cytokines A Comprehensive Evaluation of Nasal and Bronchial Cytokines and Chemokines Following Experimental Rhinovirus Infection in Allergic Asthma: Increased Interferons (IFN-γ and IFN-λ) and Type 2 Inflammation (IL-5 and IL-13)Peg-Interferon Lambda Treatment Induces Robust Innate and Adaptive Immunity in Chronic Hepatitis B Patients.Genetic variations in IL28B and allergic disease in children.IFN-λ exerts opposing effects on T cell responses depending on the chronicity of the virus infection.HHV-6B induces IFN-lambda1 responses in cord plasmacytoid dendritic cells through TLR9 Activation of type III interferon genes by pathogenic bacteria in infected epithelial cells and mouse placenta.Respiratory viral infections in children with asthma: do they matter and can we prevent them?IL-28B is a key regulator of B- and T-cell vaccine responses against influenza Bacterial pathogens activate a common inflammatory pathway through IFNλ regulation of PDCD4.Increased nuclear suppressor of cytokine signaling 1 in asthmatic bronchial epithelium suppresses rhinovirus induction of innate interferons Toll-like receptor 7 governs interferon and inflammatory responses to rhinovirus and is suppressed by IL-5-induced lung eosinophilia.Interferon-lambda as a new approach for treatment of allergic asthma?Asthma exacerbations: a molecular dichotomy between antiviral and pro-inflammatory responses revealed.Defining critical roles for NF-κB p65 and type I interferon in innate immunity to rhinovirus.Altered Expression of IFN-λ2 in Allergic Airway Disorders and Identification of Its Cell Origins Toll-like receptor 7 stimulates production of specialized pro-resolving lipid mediators and promotes resolution of airway inflammation Changes in inflammatory cytokine networks in myasthenia gravis.Impaired innate interferon induction in severe therapy resistant atopic asthmatic children Regulation of Airway Inflammation by G-protein Regulatory Motif Peptides of AGS3 protein.SET9-Mediated Regulation of TGF-β Signaling Links Protein Methylation to Pulmonary Fibrosis.Usp18 deficient mammary epithelial cells create an antitumour environment driven by hypersensitivity to IFN-λ and elevated secretion of Cxcl10 Impact of host genetic polymorphisms on vaccine induced antibody response Impaired secretion of interferons by dendritic cells from aged subjects to influenza : role of histone modifications.Impact of placental Plasmodium falciparum malaria infection on the Cameroonian maternal and neonate's plasma levels of some cytokines known to regulate T cells differentiation and function Interferon Lambda: Modulating Immunity in Infectious Diseases.IFN-λs.IFN-λ and IgE-mediated allergic disease: a potential future role?The airway epithelium in asthma.Targeting interleukins to treat severe asthma.Genetic regulation of immunoglobulin E level in different pathological states: integration of mouse and human genetics.Changing face of vaccination in immunocompromised hosts.The impact of the interferon-lambda family on the innate and adaptive immune response to viral infections.Involvement of NK Cells in IL-28B-Mediated Immunity against Influenza Virus Infection.STAT1 Represses Cytokine-Producing Group 2 and Group 3 Innate Lymphoid Cells during Viral Infection.

P2860

Q21296797-AD228514-1575-4E29-A78A-AECD6BEAC4A0 Q26801049-7C8968FF-023C-4308-B5ED-0E0E6C771B60 Q27308880-1BB1E5DB-8EEE-49A3-86DE-CDC9F0F3B45D Q28072995-5D0DA20A-35C3-41E8-830A-CEAFE2B793BF Q30661545-3978E15E-B107-42A5-B44D-7CBAB4D6A226 Q33603081-80469039-A20A-454A-89FD-C975F1922996 Q33715731-40A7B6D7-C7F7-41F4-A77C-D65D326EC7BA Q33734554-392E7FB1-AD7C-4DC4-B9C0-E57139258431 Q34147621-F96FE286-F8C7-4348-9AB7-FCCA4D12E9C4 Q34147632-BD86A4EF-D785-4F96-A1C4-04A8C9F411E3 Q34305671-5AC7E162-D0C0-448B-BA83-658D9B455353 Q34312139-8EF2D985-E726-436C-AD42-4F6DBC4FC3D8 Q34413913-E4CE25E2-9A8E-4C08-9388-D26EC709B577 Q34682206-3F76BB43-4BB9-4B98-BDBB-E5ED697A13A6 Q35008819-E96CA354-CEA1-4AF6-848C-F9562439A8A6 Q35971340-D0BC098F-2604-4A74-8B1C-3A9355240D48 Q36005193-CF22FCD9-4F2D-4D05-A8FD-670BBC2941E4 Q36038749-871272FE-78FB-4AA4-B725-9FF9540A67EC Q36492367-A0BCF023-6253-4ADE-822B-3D07C42BDCF4 Q36492384-37A4AFC3-CD43-48E0-B562-F7A66A4C935F Q36532331-53F5E612-AA67-483B-B95A-9E96369E507F Q36870120-55CE8E45-4C6F-405F-90C5-8678BD3AE680 Q36897571-5722DC6B-2E79-46F0-84DE-6C38ABB766B0 Q36935163-94E67993-5244-4E76-8750-7471B5E659F9 Q36974529-E676D39A-7F36-4F68-AF25-25FF558C239B Q37037723-7D50FBC5-515F-4937-9FF4-C8932B2757FE Q37040823-E4280CDA-A2BE-46E8-8043-EBD3E48F007F Q37130716-39BAAC35-C493-4021-9066-25F4AB094D4C Q37179927-ADB744F4-4300-4963-BB85-483EC9B7F4EE Q37426283-5041BA94-623D-46A4-A4A8-8B85AE4E09DC Q37670446-B292E2E5-C1F7-44A3-8158-FF67160BA56A Q37917252-E3611B1B-F690-44E2-8B59-017596D90B70 Q37997043-B5E07E15-5359-48D1-AF8C-84E4016292B7 Q38007828-82B7319E-1F31-4355-AC18-BB5E9500F0A0 Q38042721-C6CD81CD-3E63-463C-BF3E-F1BCFB7743C7 Q38151950-6E241338-3B71-4192-AE68-6A85AFA40958 Q38225998-62EA714C-EB33-4FCB-AE88-A1C4F31BA53A Q38514365-D9CCF1E6-0D9F-4B26-92BD-7D1B6C913C0B Q38668279-6122B645-A02D-491A-81A2-AB554E698201 Q38747454-C95A88CC-D812-4016-89A4-70DC85D53FFD

P2860

IL-28A (IFN-λ2) modulates lung DC function to promote Th1 immune skewing and suppress allergic airway disease.

http://www.wikidata.org/entity/Q41863615

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

IL-28A (IFN-λ2) modulates lung ...... press allergic airway disease.

@en

type

label

IL-28A (IFN-λ2) modulates lung ...... press allergic airway disease.

@en

prefLabel

IL-28A (IFN-λ2) modulates lung ...... press allergic airway disease.

@en

P1433

Q41863615-8F1D673B-1260-4888-BD70-FBF6294131F0

P1476

Q41863615-6ADA0C51-DD96-4860-91E3-B9009661ACEE

P2093

Q41863615-09DDEDA5-A129-434A-81F3-CA6C631BF538

Q41863615-192DA59A-FEBB-4134-B104-38B114DF87A6

Q41863615-41456A03-526C-4309-84BA-E2F1A72CC6B1

Q41863615-6576EF2D-C5FF-49B3-820F-6AB2BE6A4BAF

Q41863615-8AA459F9-0FAE-487F-909A-17B74DB18B6A

Q41863615-8CFA9E3E-E405-4DF0-97A8-83EB1D7CC89E

Q41863615-9F2A4099-1BB6-4306-967E-7764A33C14CB

Q41863615-A1A00DC9-469D-453B-97DD-67CE12B67264

Q41863615-BDA9DA58-D2C5-4551-83FB-A6F30201D069

Q41863615-CCCDE4E0-C8E2-42CB-8E8B-F0878B9DC641

P2860

Q41863615-01E1E813-8613-48A9-B18F-4BBE68A94E1A

Q41863615-064A5C4A-D55F-4EB1-A1B6-28F1405358A9

Q41863615-08EB26B1-637D-4A9A-88C7-F18B01FB0EA4

Q41863615-15986E80-CC17-4355-8F09-A9B615443879

Q41863615-15F81BAE-5EB7-46E5-8A77-F66DBE5F58D0

Q41863615-1695F418-B996-4115-946B-EF9F0FF1C231

Q41863615-1A49BB4C-225B-4DCB-8C75-26B7360E4D9D

Q41863615-34452832-1C0A-48CB-B2E5-DC58CA1C4F1D

Q41863615-4CCE743B-3263-4471-9481-7B6CE3E396AA

Q41863615-4F720547-75AC-4E21-874A-06BB8C04A7EA

P304

Q41863615-92A1DCF0-46F0-416F-A2FF-AAA03DA4334B

P31

Q41863615-AC2D4D66-D281-493A-BBD5-522DC95D97B4

P356

Q41863615-7240C51D-C89E-49BE-8DFF-C2EF9F0158ED

P433

Q41863615-752B262B-4933-49FF-A600-BAD4142B4327

P478

Q41863615-BD90E55E-DC83-4B8C-967C-E944B1481F9A

P577

Q41863615-8DA4500D-520B-4CD0-9F4E-11AEA1573F6F

P5875

Q41863615-69BB0EA9-9925-4ACA-9C4F-FE012048E86A

P698

Q41863615-770F508C-3CB1-42ED-87FD-88E2492530AF

P932

Q41863615-32EA949B-DD41-49C2-B997-CF4252C5EEC1

P356

P1433

EMBO Molecular Medicine

P1476

IL-28A (IFN-λ2) modulates lung ...... press allergic airway disease.

@en

P2093

Athanasios Stavropoulos

http://www.w3.org/2001/XMLSchema#string

Caroline Ubel

http://www.w3.org/2001/XMLSchema#string

Evangelos Andreakos

http://www.w3.org/2001/XMLSchema#string

George Tzelepis

http://www.w3.org/2001/XMLSchema#string

Hans A Lehr

http://www.w3.org/2001/XMLSchema#string

Kevin M Klucher

http://www.w3.org/2001/XMLSchema#string

Marcus Tepe

http://www.w3.org/2001/XMLSchema#string

Markus F Neurath

http://www.w3.org/2001/XMLSchema#string

Michael Hausding

http://www.w3.org/2001/XMLSchema#string

Ourania Koltsida

http://www.w3.org/2001/XMLSchema#string

P2860

IFN-lambda1 (IL-29) inhibits GATA3 expression and suppresses Th2 responses in human naive and memory T cells

IL-28, IL-29 and their class II cytokine receptor IL-28R

IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex

Allergenicity resulting from functional mimicry of a Toll-like receptor complex protein

Lambda interferon inhibits hepatitis B and C virus replication.

Characterization of the mouse IFN-lambda ligand-receptor system: IFN-lambdas exhibit antitumor activity against B16 melanoma

Modulation of human plasmacytoid DC function by IFN-lambda1 (IL-29)

Despite IFN-lambda receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokines

Interferon-lambda-treated dendritic cells specifically induce proliferation of FOXP3-expressing suppressor T cells

An important role for type III interferon (IFN-lambda/IL-28) in TLR-induced antiviral activity

P304

348-361

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/EMMM.201100142

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2011-05-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51094937

http://www.w3.org/2001/XMLSchema#string

P698

21538995

http://www.w3.org/2001/XMLSchema#string

P932

3377081

http://www.w3.org/2001/XMLSchema#string